Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.48 |
| ▸ | CES1 | P23141 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9521302 | 1.00 | CES2 (0.48) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL7481905 | 1.00 | CES2 (0.48) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL1012685 | 0.85 | CES2 (0.48) | CES2CES1ALDH1A1 | |
| SCHEMBL1012686 | 0.85 | CES2 (0.48) | CES2CES1ALDH1A1 | |
| SCHEMBL9522019 | 0.83 | CES2 (0.47) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL9522007 | 0.83 | CES2 (0.47) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL9046982 | 0.77 | CES2 (0.64) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL940243 | 0.77 | CES2 (0.64) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL2562024 | 0.77 | CES2 (0.64) | CES2CES1ALDH1A1HTTMAPK14 | |
| SCHEMBL30485086 | 0.77 | CES2 (0.64) | CES2CES1ALDH1A1HTTMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1071640-B1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | NAEJA PHARMACEUTICAL INC (CA) | 2002-03-13 | — | — | EP | disclosed |
| EP-1071640-A1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | Naeja Pharmaceutical Inc. (CA) | 2001-01-31 | — | — | EP | disclosed |
| US-6133485-A | Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols | SYNPHAR LABORATORIES, INC. (CA) | 2000-10-17 | — | — | US | disclosed |
| WO-1999052840-A1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | NAEJA PHARMACEUTICAL INC. (US) | 1999-10-21 | — | — | WO | disclosed |